D Logar
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Rheumatology 12
- Rheumatoid Arthritis Research and Therapies 7
- Systemic Lupus Erythematosus Research 5
- Musculoskeletal synovial abnormalities and treatments 2
-
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Vita Dolžan (7 shared papers)Blaž Rozman (10 shared papers)Petra Bohanec Grabar (6 shared papers)Matija Tomšič (6 shared papers)Tanja Kveder (2 shared papers)Jurij Dobovišek (1 shared paper)I. Watt (3 shared papers)Predrag Musikic (3 shared papers)
- Journals
- European Journal of Clinical Pharmacology (2 papers)Lara D. Veeken (2 papers)Clinical Rheumatology (1 paper)Lupus (1 paper)Disease Markers (1 paper)
- Partner nations
- SloveniaUnited KingdomAustria
In The Last Decade
D Logar
17 papers receiving 496 citations
Peers
Comparison fields: 5 of 60
- Rheumatology 307
- Genetics 55
- Pharmacology 28
- Hematology 35
- Immunology 63
Countries citing papers authored by D Logar
This map shows the geographic impact of D Logar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Logar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Logar more than expected).
Fields of papers citing papers by D Logar
This network shows the impact of papers produced by D Logar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Logar. The network helps show where D Logar may publish in the future.
Co-authors
The 25 scholars most cited alongside D Logar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 105 | |
| 2 | 1990 | 75 | |
| 3 | 2008 | 60 | |
| 4 | 2009 | 35 | |
| 5 | Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis. | 2009 | 32 |
| 6 | 1993 | 31 | |
| 7 | 2012 | 26 | |
| 8 | Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients. | 1997 | 25 |
| 9 | 1996 | 25 | |
| 10 | 2009 | 24 | |
| 11 | 2012 | 24 | |
| 12 | 1993 | 22 | |
| 13 | 1994 | 14 | |
| 14 | 2002 | 6 | |
| 15 | 2006 | 5 | |
| 16 | 2002 | 1 | |
| 17 | Recurrent sepsis and seronegative arthritis in a patient with a selective IgG3 deficiency. | 2000 | 1 |
About D Logar
D Logar is a scholar working on Rheumatology, Immunology, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 17 papers that have together received 511 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (5 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Viral Infections and Immunology Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Musculoskeletal synovial abnormalities and treatments (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Bone and Joint Diseases (1 paper). The work is most often cited by research in Rheumatology (307 citations), Genetics (55 citations), Pharmacology (28 citations), Hematology (35 citations) and Immunology (63 citations). D Logar has collaborated with scholars based in Slovenia, United Kingdom and Austria. Frequent co-authors include Vita Dolžan, Blaž Rozman, Petra Bohanec Grabar, Matija Tomšič, Tanja Kveder, Jurij Dobovišek, I. Watt, Predrag Musikic, G. Campion and Franci Demšar. Their work appears in journals such as European Journal of Clinical Pharmacology, Lara D. Veeken, Clinical Rheumatology, Lupus and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.